Cargando…
Serum Procalcitonin as a Predictive Biomarker in COVID-19: A Retrospective Cohort Analysis
Introduction: Since the onset of COVID-19, physicians and scientists have been working to further understand biomarkers associated with the infection, so that patients who have contracted the virus can be treated. Although COVID-19 is a complex virus that affects patients differently, current resear...
Autores principales: | Hussain, Aaiz, Singh, Lavi, McAlister III, James, Jo, Yongho, Makaryan, Tadevos T, Hussain, Shaheer, Trenschel, Robert W, Kesselman, Marc M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452059/ https://www.ncbi.nlm.nih.gov/pubmed/36106293 http://dx.doi.org/10.7759/cureus.27816 |
Ejemplares similares
-
A Review of the Value of Procalcitonin as a Marker of Infection
por: Taylor, Richard, et al.
Publicado: (2017) -
Mycobacterium abscessus Complex Osteomyelitis of the Wrist
por: Alter, Noah, et al.
Publicado: (2022) -
Cardiovascular Risk Associated With TNF Alpha Inhibitor Use in Patients With Rheumatoid Arthritis
por: Hussain, Aaiz, et al.
Publicado: (2021) -
A Review of the Efficacy of Influenza Vaccination in Autoimmune Disease Patients
por: Abdelahad, Mandi, et al.
Publicado: (2021) -
Optimal use of procalcitonin to rule out bacteremia in patients with possible viral infections
por: Azijli, Kaoutar, et al.
Publicado: (2022)